Diffusion Pharmaceuticals Inc. DFFN Income Statement

Diffusion pharmaceuticals inc. (DFFN)

Income statement / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Sep'11	Jun'11	Sep'10	Jun'10
Events
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	89	-	-	-	-
Licensing
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	70	-	-	-	-
Revenues
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-71	143	143	159	250	0	-	0
Cost of revenues
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	5	0	0	228	253	0	-	0
Gross margin
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-77	142	142	-68	-3	0	-	0
Operating expenses:
Research and development
1,534	1,657	1,743	1,518	1,699	1,365	1,169	1,391	1,825	1,142	1,759	1,179	1,007	1,512	1,941	1,444	2,352	1,272	922	948	731	1,151	1,273	266	169	-	-	-	-	-	-	-	-	-	-	-	-
General and administrative
1,393	1,274	1,290	1,068	1,200	1,419	1,589	1,660	1,497	1,283	1,559	1,795	1,553	1,030	3,852	2,349	3,862	1,294	421	347	458	668	1,869	1,210	1,010	5,744	448	514	624	996	1,055	1,055	1,462	2,551	1,119	510	641
Goodwill impairment
-	-	-	-	-	-	4,186	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation
27	27	18	34	18	28	26	26	28	28	27	5	6	5	5	5	7	2	2	1	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Impairment of other intangible assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,935	-	-	-	197	-	-	-	-	-
Impairment of intangible assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	197	-	-	0	-	-	-
Warrants, options and stock compensation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	631	2,279	1,316	-350	1,877	1,877	240	331	381	635	806
Fair value of common stock exchanged for warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-
Fair value of common stock exchanged for warrants and notes payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3,069	-	-	-	-	-	-	-	-	-
Legal and professional services
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	576	290	143	701	428	428	570	1,231	542	484	359
Depreciation and amortization
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-317	368	323	191	92	7	7	8	134	9	9	9	21	13	12	12
Former employee severance expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-
TOTAL EXPENSES
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	7,928	3,511	1,801	1,371	942	1,664	8,097	2,092	2,509	3,568	3,568	2,283	4,136	2,056	1,643	1,820
Loss from operations
-2,955	-2,959	-3,052	-2,621	-2,918	-5,556	-6,972	-3,078	-3,351	-2,453	-3,346	-2,981	-2,567	-2,548	-5,799	-3,799	-6,223	-2,569	-1,346	-1,297	-1,192	-7,928	-3,511	-1,801	-1,371	-942	-1,664	-8,097	-2,092	-2,587	-3,426	-3,426	-2,352	-4,140	-2,056	-1,643	-1,820
Other income:
Interest income
34	25	21	16	20	30	37	45	37	25	1	-18	-55	-	-1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gain on adjustments to fair value of derivative liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	9,216	-236	-	-	-2,022	-	-	-	-	-
Gain on extinguishment of derivative liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,409	-	-	-	0	-	-	-	-	-
Loss on settlement of notes payable - related parties
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-1,829	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss on settlement of notes payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-876	-	-	-	-	-	-	-	-	-	-	-	-	-
Other (income) expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-29	3	2	49	-689	49	-17	-2	-	-	-133	-	-	-	-	-
Interest expense, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	6	0	152	76	33	50	-8	86	136	58	101	13	35	-22	-	-	-52	-	-	-	-	-
Change in fair value of warrant liability
-	-	-	-	-	-	-	-	-	-3,162	-8,441	-23,387	12,919	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Warrant related expenses
-	-	-	-	-	-	-	-	-	0	0	0	10,225	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Warrant related expenses (Note 7)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
(Gain)/loss on adjustments to fair value of derivative liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-17,915	2,047	-	-	-	-
Other financing expenses
-	-	-	-	-	-	-	-	-	0	0	0	2,870	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-133	760	0	0	0	168	-
Interest expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	172	49	2	195	88	21	17
TOTAL OTHER (INCOME)/EXPENSES
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	376	-83	-2,840	-8	-1,038	36	10,573	257	-4,844	-38	-2,104	2,045	-195	-88	-189	-17
Loss from operations before income tax benefit
-2,921	-2,933	-3,030	-2,604	-2,898	-5,525	-6,934	-3,033	-3,313	-	5,096	20,387	-	-	-5,801	-	-	-	-1,422	-	-	-	-3,595	-4,641	-	-	-	-	-	-	-	-	-	-	-	-	-
Income tax benefit
-362	818	-225	-108	-150	-	-214	-267	-	-	0	0	-	-	-364	-	-	-	0	-	-	-	-145	-186	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss attributed to non-controlling interests
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	25	10	0	-16	-	-	-	-
Net loss
-2,558	-3,752	-2,804	-2,495	-2,747	-5,570	-6,719	-2,765	-3,313	1,789	5,096	20,387	-28,638	-2,570	-5,436	-3,806	-6,223	-2,721	-1,422	-1,331	-1,243	-	-	-	-	-	-	-	-	-1,791	-3,464	-1,322	-290	-4,335	-2,145	-1,832	-1,837
Accretion of Series A cumulative preferred dividends
-	-	-	-	-	0	0	0	85	339	366	487	58	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Undistributed earnings to participating securities
-	-	-	-	-	-	-	-	-	-	1,838	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deemed dividend related to the make-whole provision for the conversion of Series A convertible preferred stock into common stock
-	-	-	-	-	0	0	0	8,167	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
LOSS FROM CONTINUING OPERATIONS
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,466	-1,628	2,476	-2,349	-	-	-	-	-	-	-	-
Income from discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	656	102	-129	-126	-	-	-	-	-	-	-	-
NET LOSS
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-809	-1,525	2,347	-2,476	15,947	-21,168	-1,322	-307	-	-	-	-
Preferred dividends
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	47	-	-	-	-	-	-	-	-	-
Preferred dividends
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	124,375.00	131,750.00	121,505.00	119,744.00	124,168.00	-	-	-	-
Net loss attributable to common stockholders
-	-	-2,804	-2,495	-	-5,570	-6,719	-2,765	-11,567	3,288	2,891	19,900	-28,697	-	-	-	-6,223	-	-	-	-	-5,067	-3,449	-4,455	-1,380	-809	-1,525	2,300	-2,601	15,791	-21,300	-1,441	-415	-	-	-	-
Per share information:
Net loss per share of common stock, basic and diluted (in dollars per share)
-0.07	0.28	-0.60	-0.63	-0.81	-1.29	-1.99	-0.82	-4.11	-	0.21	0.88	-	-	-0.53	-0.37	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Weighted average shares outstanding, basic and diluted (in dollars per share)
34,507,496.00	-5,303,695.00	4,693,290.00	3,940,684.00	3,376,230.00	-6,313,253.00	3,371,468.00	3,369,770.00	2,814,316.00	-	0.20	-1.00	-	-	-0.53	-0.37	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Basic and diluted loss per share for continuing operations - attributable to RestorGenex Corporation (in dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.10	-0.39	0.87	-2.77	-	-	-	-	-	-	-	-
Basic and diluted income per share for discontinued operations (in dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.36	0.02	-0.05	-0.14	-	-	-	-	-	-	-	-
Net loss per share of common stock, basic and diluted (in dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-2.78	-	-	-	-0.62	-1.80	-0.64	-0.06	-0.06	-0.24	-0.18	-0.35	-0.23	1.46	-0.37	0.82	-2.91	-8.10	-0.04	-0.02	0.00	-0.06	-0.03	-0.03	-0.03
Weighted average shares outstanding, basic and diluted (in shares)
-	-	-	-	-	-	-	-	-	-	-	-	10,337	-	-	-	9,996	-35,917	2,222	22,087	22,087	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Weighted average shares outstanding, basic (in shares)
-	-	-	-	-	-	-	-	-	-	13,937	10,828	-	-	10,333	10,263	-	-	-	-	-	19,724	18,671	12,867	5,934	-	-	-	-	-	89,748	-	-	77,535	71,161	62,522	60,768
BASIC WEIGHTED AVERAGE SHARES OUTSTANDING
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,687	4,144	2,862	892	-264,048	89,755	89,748	88,157	-	-	-	-
Weighted average shares outstanding, diluted (in shares)
-	-	-	-	-	-	-	-	-	-	14,714	13,872	-	-	10,333	10,263	-	-	-	-	-	19,724	18,671	12,867	5,934	2,372	4,144	2,862	1,207	-347,672	124,838	117,915	109,407	-	-	-	-